Symptoms of Depression Among Adults: United States, 2019
- PMID: 33054920
Symptoms of Depression Among Adults: United States, 2019
Abstract
Depression is characterized by the presence of feelings of sadness, emptiness, or irritability, accompanied by bodily and cognitive changes lasting at least 2 weeks that significantly affect the individual's capacity to function (1). The eight-item Patient Health Questionnaire (PHQ-8) is a validated diagnostic and severity measure of symptoms of depressive disorders (2,3). Adults with scores of 0-4 are considered to have no or minimal symptoms of depression, while those with scores of 5-9, 10-14, or 15-24 are considered to have mild, moderate, or severe symptoms, respectively (2,3). This report examines the percentage of adults aged 18 and over with symptoms of depression in the past 2 weeks in 2019, by symptom severity and select demographic characteristics, using the PHQ-8 scale.
All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
Similar articles
-
The PHQ-8 as a measure of current depression in the general population.J Affect Disord. 2009 Apr;114(1-3):163-73. doi: 10.1016/j.jad.2008.06.026. Epub 2008 Aug 27. J Affect Disord. 2009. PMID: 18752852
-
Enhancing electronic health record measurement of depression severity and suicide ideation: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study.J Am Board Fam Med. 2012 Sep-Oct;25(5):582-93. doi: 10.3122/jabfm.2012.05.110053. J Am Board Fam Med. 2012. PMID: 22956694
-
Symptoms of Generalized Anxiety Disorder Among Adults: United States, 2019.NCHS Data Brief. 2020 Sep;(378):1-8. NCHS Data Brief. 2020. PMID: 33054928
-
Assessing the prevalence of depression among individuals with diabetes in a Medicaid managed-care program.Int J Psychiatry Med. 2008;38(1):13-29. doi: 10.2190/PM.38.1.b. Int J Psychiatry Med. 2008. PMID: 18624014
-
Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents.J Child Adolesc Psychopharmacol. 2019 Feb;29(1):34-40. doi: 10.1089/cap.2018.0112. Epub 2018 Nov 2. J Child Adolesc Psychopharmacol. 2019. PMID: 30388048 Free PMC article.
Cited by
-
Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use.Front Psychiatry. 2022 Sep 28;13:992624. doi: 10.3389/fpsyt.2022.992624. eCollection 2022. Front Psychiatry. 2022. PMID: 36245861 Free PMC article.
-
Resistance training for Black men with depressive symptoms: a pilot randomized controlled trial to assess acceptability, feasibility, and preliminary efficacy.BMC Psychiatry. 2022 Apr 21;22(1):283. doi: 10.1186/s12888-022-03935-x. BMC Psychiatry. 2022. PMID: 35448974 Free PMC article. Clinical Trial.
-
Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women.J Neurol. 2023 Apr;270(4):2069-2083. doi: 10.1007/s00415-022-11541-w. Epub 2022 Dec 26. J Neurol. 2023. PMID: 36572715 Free PMC article.
-
Recruitment and engagement in disease self-management programs: Special concerns for rural residents reporting depression and/or anxiety.Prev Med Rep. 2022 Mar 8;26:101761. doi: 10.1016/j.pmedr.2022.101761. eCollection 2022 Apr. Prev Med Rep. 2022. PMID: 35299592 Free PMC article.
-
How Income and Income Inequality Drive Depressive Symptoms in U.S. Adults, Does Sex Matter: 2005-2016.Int J Environ Res Public Health. 2022 May 20;19(10):6227. doi: 10.3390/ijerph19106227. Int J Environ Res Public Health. 2022. PMID: 35627767 Free PMC article.
MeSH terms
LinkOut - more resources
Miscellaneous